Dissemination of the WiseApp for Improving Health Outcomes Across Settings (WiseApp in Spanish)
Principal Investigator
Rebecca Schnall, PhD, MPH, BSN, FAAN, FACMI
- Mary Dickey Lindsay Professor of Disease Prevention and Health Promotion (in Nursing) and Professor of Population and Family Health
About the Study
The purpose of this research study is to assess the effectiveness of using a mobile health (mHealth) approach to improving the quality of life for Spanish-speaking people living with HIV (PLWH) in the United States (New York City) and the Dominican Republic (La Romana).
This in-person study will recruit 248 participants and will take place in the New York-Presbyterian (NYP) Hospital in Washington Heights for the NYC site and at the Clínica de Familia La Romana in La Romana for the DR site. The procedures in this study are to complete surveys and blood draws every three months after enrollment (no study procedures for the 9-month mark). Participants will be randomly assigned to one of two groups. Some participants will receive a pill bottle dispenser and access to a mobile application (app), while other participants will receive a standard of care.
The time frame for your involvement in the study is one year. Study participants will receive up to USD$220 after finishing the 12-month study.
For Participants
- The "WiseApp in Spanish study" is a 12-month study looking at how a phone app and a pill dispenser can help Spanish-speaking people living with HIV monitor and improve their overall quality of life. The study involves 4 site visits to a clinic in Washington Heights (NYC) or Clínica de Familia La Romana (DR), which will include taking a blood sample and completing a survey on an iPad (for all 4 visits). At the end of the first visit, some participants will be asked to use a daily pill dispenser for their HIV medication and to use a health app on their phone during their participation in the study.
- List inclusion criteria:
- Able to speak, read, and write in Spanish.
- Aged ≥18 years.
- Willing to participate in any assigned arm of the intervention.
- Having been diagnosed with HIV ≥6 months ago.
- Have an HIV-1 RNA level >50 copies/mL.
- viral load >50.
- Own a smartphone.
- Ability and willingness to provide informed consent for study participation and consent for access to medical records.
- Link for the screener
- Resources detailing participant profile:
Benefits
There may be no direct benefit to you for participating in this study. Although it cannot be guaranteed, you may benefit from improved self-management of your HIV by being in this study.
Alternative Procedures
The alternative is not to participate. You are free to refuse to participate or to withdraw from this research at any time.
Confidentiality
Any information collected during this study that can identify you by name will be kept confidential. We will do everything we can to keep your data secure.
Voluntary Participation
Participation in this research is voluntary. You are free to decline to be in this study, or to withdraw from it at any point.
For Researchers
The purpose of this research study is to assess the effectiveness of using a mobile health (mHealth) approach to improving the quality of life for Spanish-speaking people living with HIV (PLWH) in the United States (New York City) and the Dominican Republic (La Romana).
More information can be found on ClinicalTrials.Gov
You can also see if you qualify for the study using the Columbia RecruitMe
En Español
- El estudio Diseminación de la WiseApp para Mejorar Estados de Salud a Través de Diferentes Ambientes, también conocido como WiseApp en español tiene como propósito evaluar la efectividad del uso de un enfoque de salud móvil (mHealth, por su nombre en inglés) para mejorar la calidad de vida de las personas que viven con el VIH en los Estados Unidos (Ciudad de Nueva York) y la República Dominicana (La Romana).
- Los procedimientos de este estudio consisten en realizar encuestas y extracciones de sangre cada tres meses después de la inscripción (no se realizarán procedimientos de estudio a los nueve meses de comenzar la participación). Los participantes serán asignados aleatoriamente a uno de dos grupos. Algunos participantes recibirán un dispensador de pastillas y acceso a una aplicación móvil, mientras que otros participantes recibirán un tratamiento estándar de atención médica.
- El tiempo de su participación en el estudio es de un año. Los participantes del estudio recibirán hasta USD$220 dólares después de finalizar el estudio de 12 meses.
- Comuníquese con nuestro equipo de investigación para obtener más información o use el enlace a continuación para saber si es elegible para participar: